Well, Amgen is a very intriguing potential investment right now. Its second quarter featured revenue up 9% year over year, ...

Biotech company invests in its roots in Thousand Oaks. On Tuesday, the business announced the building of a 'state-of-the-art ...

Rory McIlroy holed a dramatic 28-foot eagle putt on the final hole to force a playoff, then went on to top Joakim Lagergren ...

Angel Hidalgo came up just short of making DP World Tour history on Saturday. His third-round 63 at the Amgen Irish Open ...

Suddenly one obesity asset has come to define Amgen but executives see a fuller portfolio that will bring the big biotech ...

Jefferies analysts expect a regulatory filing for rocatinlimab later this year, with a product launch in 2026.

The biotech company is Ventura County's largest private-sector employer, but most of its recent growth has happened outside ...

The DP World Tour previously announced the schedule for next year, and it was Donald Trump's course that attracted enormous ...

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab ...

Amgen (AMGN) stock in focus as the company and Kyowa Kirin (KYKOF) report Phase 3 data showing their atopic dermatitis drug, ...

Across the Phase 3 ROCKET program including ASCEND, the incidence of gastrointestinal ulceration events with rocatinlimab to date is less than 1 per 100 patient-years. The ASCEND study is ongoing and ...

Amgen Inc. ( NASDAQ: AMGN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT ...